Sera Prognostics (SERA) Long-Term Debt Repayments (2020 - 2021)
Sera Prognostics' (SERA) quarterly Long-Term Debt Repayments came in at $4.5 million in Q1 2021, up 349.4% on a QoQ basis from $1.0 million in Q4 2020.
Sera Prognostics (SERA) Long-Term Debt Repayments (2020 - 2021) Analysis & Trends
Sera Prognostics (SERA) has 2 years of Long-Term Debt Repayments data on file, last reported at $4.5 million in Q1 2021.
- Quarterly Long-Term Debt Repayments changed N/A year-over-year to $4.5 million in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $4.5 million (changed N/A YoY) and the FY2021 annual result came in at $4.5 million, up 68.5% from the prior year.
- Long-Term Debt Repayments advanced to $4.5 million in Q1 2021, from $1.0 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $4.5 million in Q1 2021 to a low of $1.0 million in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.41 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -927.56 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 4.49 Mn |
| Mar 31, 2021 | 4.49 Mn |
| Dec 31, 2020 | 1.00 Mn |
| Dec 31, 2020 | 1.00 Mn |
| Sep 30, 2020 | 1.00 Mn |
| Sep 30, 2020 | 1.00 Mn |